Mereo BioPharma Group plc - SPON ADS (MREO)

Historical Portfolio Holders from Q2 2019 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPON ADS
Shares, excl. options Q3 2024
106M
Holdings value Q3 2024
$435M
Value change Q3 2024
+$21.8M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
76
Number of buys Q3 2024
29
Number of sells Q3 2024
-32
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 106M $435M +$21.8M $4.11 76
2024 Q2 101M $362M +$59.8M $3.60 76
2024 Q1 84M $277M +$19.4M $3.30 77
2023 Q4 78.5M $181M +$20.4M $2.31 61
2023 Q3 69.9M $90.2M +$9.89M $1.29 52
2023 Q2 63.6M $84M +$9.81M $1.32 49
2023 Q1 60.8M $43M -$604K $0.71 56
2022 Q4 61.4M $46.1M -$7.74M $0.75 57
2022 Q3 68M $58.5M -$7.13M $0.86 56
2022 Q2 73.6M $82.5M -$16.9M $1.12 58
2022 Q1 88.9M $99.6M -$3.07M $1.12 55
2021 Q4 90.9M $145M -$12.2M $1.60 67
2021 Q3 87.5M $212M -$26.7M $2.42 58
2021 Q2 89.6M $284M -$2.19M $3.17 68
2021 Q1 90.2M $304M +$111M $3.37 65
2020 Q4 57.1M $205M +$139M $3.58 44
2020 Q3 14.3M $38.1M +$18.6M $2.62 22
2020 Q2 7.28M $22.3M +$12.6M $3.06 20
2020 Q1 3.28M $3.42M +$2.08M $1.04 8
2019 Q4 1.24M $4.08M -$2.39M $3.28 10
2019 Q3 1.78M $5.21M -$42.9K $2.98 14
2019 Q2 1.8M $4.38M +$4.38M $2.52 15